Retrospective Comparison of Efficacy and Safety of Basiliximab and Antithymocyte Globulin in Kidney Transplant Recipients. KJPS [Internet]. 2021 Aug. 11 [cited 2026 Jul. 12];1(1). Available from: https://onlinejournals.uofk.edu/KJPS/article/view/40